Kura Oncology
KURA
KURA
171 hedge funds and large institutions have $1.94B invested in Kura Oncology in 2021 Q1 according to their latest regulatory filings, with 12 funds opening new positions, 70 increasing their positions, 55 reducing their positions, and 37 closing their positions.
New
Increased
Maintained
Reduced
Closed
more call options, than puts
Call options by funds: $ | Put options by funds: $
more funds holding in top 10
Funds holding in top 10: →
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
more ownership
Funds ownership: →
9% less capital invested
Capital invested by funds: $2.12B → $1.94B (-$183M)
14% less funds holding
Funds holding: 198 → 171 (-27)
68% less first-time investments, than exits
New positions opened: 12 | Existing positions closed: 37
Holders
171
Holding in Top 10
7
Calls
$17M
Puts
$446K
Top Buyers
| 1 | +$54.3M | |
| 2 | +$40M | |
| 3 | +$39.9M | |
| 4 |
Holocene Advisors
New York
|
+$17.6M |
| 5 |
EAM
Eventide Asset Management
Boston,
Massachusetts
|
+$15.8M |
Top Sellers
| 1 | -$46.1M | |
| 2 | -$21.2M | |
| 3 | -$17.5M | |
| 4 |
CS
Credit Suisse
Zurich,
Switzerland
|
-$17M |
| 5 |
N
Nuveen
Charlotte,
North Carolina
|
-$12.5M |